n-(2,6-dimethylergoline-8-yl)-2,2-dimethylpropanamide has been researched along with ergoline in 13 studies
| Studies (n-(2,6-dimethylergoline-8-yl)-2,2-dimethylpropanamide) | Trials (n-(2,6-dimethylergoline-8-yl)-2,2-dimethylpropanamide) | Recent Studies (post-2010) (n-(2,6-dimethylergoline-8-yl)-2,2-dimethylpropanamide) | Studies (ergoline) | Trials (ergoline) | Recent Studies (post-2010) (ergoline) |
|---|---|---|---|---|---|
| 14 | 0 | 0 | 4,324 | 381 | 441 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 13 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ekman, A; Eriksson, E | 1 |
| Carlsson, A; Ekman, A; Hoffmann, WE; Lum, JT; Piercey, MF; Svensson, K | 1 |
| Clark, D; Ericsson, M; Furmidge, LJ; Johnson, D; Petry, N; Tong, ZY | 1 |
| Coward, DM; Dixon, AK; Enz, A; Karobath, M; Shearman, G; Urwyler, S; White, TG | 1 |
| Spealman, RD | 1 |
| Alling, K; Flores, P; Katz, JL; Pellón, R; Witkin, JM | 1 |
| Koob, GF; Pulvirenti, L; Smith, D | 1 |
| Baldessarini, RJ; Huston-Lyons, D; Marsh, ER | 1 |
| Ackerman, JM; Clark, D; Johansen, PA; White, FJ | 1 |
| Gerlach, J; Peacock, L | 1 |
| Deroche, V; Koob, GF; Weiss, F; Weissenborn, R | 1 |
| Balducci, C; Bono, G; Koob, GF; Pulvirenti, L; Richelmi, P | 1 |
| Bergman, J; Tidey, JW | 1 |
13 other study(ies) available for n-(2,6-dimethylergoline-8-yl)-2,2-dimethylpropanamide and ergoline
| Article | Year |
|---|---|
Effects of N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline on the prolactin suppression induced by a series of full and partial dopamine D2 receptor agonists in male rats.
Topics: 4-Butyrolactone; Adrenergic alpha-Antagonists; Animals; Apomorphine; Dopamine Agents; Ergolines; Levodopa; Male; Piperidines; Prolactin; Quinolines; Rats; Rats, Sprague-Dawley | 1992 |
Effects of the partial dopamine receptor agonists SDZ 208-911, SDZ 208-912 and terguride on central monoamine receptors. A behavioral, biochemical and electrophysiological study.
Topics: 4-Butyrolactone; Animals; Behavior, Animal; Brain; Dopamine; Dopamine Agents; Ergolines; Lisuride; Male; Motor Activity; Neurons; Quinpirole; Rats; Rats, Inbred Strains; Receptors, Dopamine; Receptors, Serotonin; Reserpine; Serotonin; Substantia Nigra; Time Factors | 1991 |
Behavioural profile of partial D2 dopamine receptor agonists. 1. Atypical inhibition of d-amphetamine-induced locomotor hyperactivity and stereotypy.
Topics: Animals; Dextroamphetamine; Dopamine Agents; Dose-Response Relationship, Drug; Ergolines; Lisuride; Motor Activity; Piperidines; Rats; Rats, Inbred Strains; Receptors, Dopamine; Receptors, Dopamine D2; Stereotyped Behavior | 1991 |
Partial dopamine-agonistic and atypical neuroleptic properties of the amino-ergolines SDZ 208-911 and SDZ 208-912.
Topics: 4-Butyrolactone; Animals; Antipsychotic Agents; Apomorphine; Avoidance Learning; Behavior, Animal; Catalepsy; Dopamine; Dopamine Agents; Ergolines; Female; Male; Prolactin; Rats; Rats, Inbred Strains; Receptors, Dopamine | 1990 |
Discriminative stimulus effects of cocaine in squirrel monkeys: lack of antagonism by the dopamine D2 partial agonists terguride, SDZ 208-911, and SDZ 208-912.
Topics: Animals; Cocaine; Discrimination, Psychological; Dopamine Agonists; Dose-Response Relationship, Drug; Ergolines; Lisuride; Male; Receptors, Dopamine D2; Saimiri | 1995 |
Pharmacological analysis of the scratching produced by dopamine D2 agonists in squirrel monkeys.
Topics: Animals; Behavior, Animal; Diphenhydramine; Dopamine Agonists; Dose-Response Relationship, Drug; Ergolines; Male; Quinpirole; Receptors, Dopamine D1; Receptors, Dopamine D2; Saimiri; Stereoisomerism | 1995 |
SDZ 208-911, an amino-ergoline with partial dopamine agonist properties, dose dependently increases cocaine self-administration in the rat.
Topics: Animals; Cocaine; Dopamine Agonists; Dose-Response Relationship, Drug; Ergolines; Male; Rats; Rats, Wistar; Reinforcement Schedule; Self Administration | 1994 |
Effects of dopamine partial-agonist aminoergolines on dopamine metabolism in limbic and extrapyramidal regions of rat brain.
Topics: 4-Butyrolactone; Animals; Dihydroxyphenylalanine; Dopamine; Dopamine Agents; Dose-Response Relationship, Drug; Ergolines; Extrapyramidal Tracts; Hydrazines; Limbic System; Male; Rats; Rats, Sprague-Dawley | 1994 |
Electrophysiological effects of putative autoreceptor-selective dopamine agonists on A10 dopamine neurons.
Topics: Animals; Azepines; Dopamine; Dopamine Agents; Electrophysiology; Ergolines; Indoles; Male; Neurons; Phenanthrenes; Rats; Rats, Sprague-Dawley | 1993 |
Effects of several partial dopamine D2 receptor agonists in Cebus apella monkeys previously treated with haloperidol.
Topics: Administration, Oral; Amphetamine; Animals; Antipsychotic Agents; Behavior, Animal; Benzothiazoles; Cebus; Disease Models, Animal; Dopamine Agents; Dopamine D2 Receptor Antagonists; Dyskinesia, Drug-Induced; Dystonia; Ergolines; Female; Haloperidol; Lisuride; Male; Piperidines; Pramipexole; Quinpirole; Raclopride; Salicylamides; Thiazoles | 1993 |
Effects of dopamine agonists and antagonists on cocaine-induced operant responding for a cocaine-associated stimulus.
Topics: Animals; Benzazepines; Bromocriptine; Cocaine; Conditioning, Operant; Dopamine Agonists; Dopamine Antagonists; Dose-Response Relationship, Drug; Ergolines; Male; Raclopride; Rats; Rats, Wistar; Reinforcement, Psychology; Salicylamides; Self Administration | 1996 |
Dopamine partial receptor agonists reduce ethanol intake in the rat.
Topics: Alcohol Drinking; Animals; Dopamine Agonists; Ergolines; Male; Rats; Rats, Wistar | 1996 |
Drug discrimination in methamphetamine-trained monkeys: agonist and antagonist effects of dopaminergic drugs.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Adrenergic Agents; Animals; Benzazepines; Catalepsy; Discrimination Learning; Dopamine Agonists; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Dose-Response Relationship, Drug; Ergolines; Male; Methamphetamine; Oxazines; Receptors, Dopamine D1; Receptors, Dopamine D2; Saimiri | 1998 |